Management of immune thrombocytopenic purpura in children.

  title={Management of immune thrombocytopenic purpura in children.},
  author={Helmut Gadner},
  journal={Reviews in clinical and experimental hematology},
  volume={5 3},
  pages={201-21; discussion 311-2}
  • Helmut Gadner
  • Published 2001 in Reviews in clinical and experimental hematology
Immune thrombocytopenic purpura (ITP) is the most common acquired bleeding disorder occurring in previously healthy children and can be classified into two major forms. Acute and chronic ITP are benign conditions with a high probability of spontaneous recovery with or without therapy. Rates of 80-90% complete remission can be achieved irrespective of the treatment given. In only 10-20% of children thrombocytopenia persists for more than six months, showing a chronic course, which also has a… CONTINUE READING